Research
Short, measured answers to the questions biotech investors and founders actually argue about.
Featured · November 2026 · 4 min read
How many rivals is too many?
A rival on your target helps your drug. A crowd of rivals hurts your chance of being bought.
2.5xmore likely to reach Phase 3 with a rival in the clinic
0.54xas likely to be acquired at 12+ recent rivals
Point in time
Every number uses only what was public on the date it describes. Nothing learned later leaks back into the past.
Measured, with its n
Each result shows how many companies or drugs stand behind it, and how wide the uncertainty is.
Plain about limits
Every note says what it cannot show. Associations are called associations.